We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

FIND Receives Grant for Diagnostics from Dutch Government

By Labmedica staff writers
Posted on 29 Nov 2006
The Dutch Government has approved the Foundation for Innovative New Diagnostics' (FIND, Geneva, Switzerland) application for a grant to develop improved diagnostics for tuberculosis (TB), the human immunodeficiency virus (HIV), and malaria.

The grant amounts to U.S.$10.1 million over a period of four years, beginning November 2006. The grant is to finance gaps in existing plans and programs to develop simple, accurate, and rapid molecular tests for TB, HIV, and malaria.

The point-of-care products to be developed by FIND will include chemical sensor arrays for the detection of volatile compounds in the sputum of TB infected individuals, an improved lateral-flow assay to diagnose malaria in a finger-prick blood sample, and a lateral-flow assay to diagnose TB by detecting Mycobacterium tuberculosis (MTb) antigens in urine.

FIND also plans to develop a simple nucleic acid amplification test for the detection of TB in urine, a simple amplification test for the detection of malaria from whole blood, and a hands-free automated nucleic acid amplification test (NAAT) for HIV viral load in blood at first-referral laboratory level.

In the first quarter of 2007 FIND plans to launch a project on laboratory preparedness for the introduction of new technologies in Uganda, with the aim to strengthen laboratory diagnostic services in that country.




Related Links:
FIND

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA

Latest Industry News

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
29 Nov 2006  |   Industry

Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
29 Nov 2006  |   Industry

New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
29 Nov 2006  |   Industry